A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CXW SEC filings page.
CoreCivic, Inc. (CXW) reported $2.5B in revenue over the twelve months to Jun 30, 2026, up 24.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 growth lifted reported earnings, but heavier reinvestment reduced post-capex cash and expanded the balance sheet.
Operating cash conversion remained positive: operating cash flow was$194.6M against net income of$116.5M , so reported earnings did become cash before reinvestment. Yet free cash flow was only$52.8M while capital expenditures consumed72.9% of operating cash flow, showing that capital spending absorbed the benefit rather than weak operations causing the shortfall.
Revenue reached
Balance-sheet financing became heavier: liabilities rose
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of CoreCivic, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
CoreCivic, Inc.'s revenue grew 12.7% year-over-year to $2.2B, a solid pace of expansion. This earns a growth score of 59/100.
CoreCivic, Inc. has a moderate D/E ratio of 0.86. This balance of debt and equity financing earns a leverage score of 50/100.
CoreCivic, Inc.'s current ratio of 1.66 indicates adequate short-term liquidity, earning a score of 48/100. The company can meet its near-term obligations, though with limited headroom.
While CoreCivic, Inc. generated $194.6M in operating cash flow, capex of $141.8M consumed most of it, leaving $52.8M in free cash flow. This results in a low score of 50/100, reflecting heavy capital investment rather than weak cash generation.
CoreCivic, Inc.'s ROE of 8.3% shows moderate profitability relative to equity, earning a score of 62/100. This is up from 4.6% the prior year.
CoreCivic, Inc. passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
For every $1 of reported earnings, CoreCivic, Inc. generates $1.67 in operating cash flow ($194.6M OCF vs $116.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
CoreCivic, Inc. generated $684.9M in revenue in Q2 2026. This represents an increase of 27.3% from the same quarter a year earlier. Against the prior quarter it is up 11.4%.
CoreCivic, Inc. reported $37.1M in net income in Q2 2026. This represents a decrease of 3.6% from the same quarter a year earlier. Against the prior quarter it is down 2.1%.
CoreCivic, Inc. earned $0.37 per diluted share (EPS) in Q2 2026. This represents an increase of 5.7% from the same quarter a year earlier. Against the prior quarter it is down 2.6%.
Not reported for Q2 2026.
Cash & Balance Sheet
CoreCivic, Inc. generated $94.9M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 53.5% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
CoreCivic, Inc. held $108.9M in cash against $1.2B in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
CoreCivic, Inc.'s net profit margin was 5.4% in Q2 2026, showing the share of revenue converted to profit. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.
CoreCivic, Inc.'s quarterly ROE was 2.6% in Q2 2026: one quarter's net income over shareholder equity, not annualized. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
CoreCivic, Inc. spent $48K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 99.9% from the same quarter a year earlier. Against the prior quarter it is down 99.9%.
CoreCivic, Inc. invested $38.1M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 9.2% from the same quarter a year earlier. Against the prior quarter it is up 84.1%.
Not reported for Q2 2026.
CXW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $684.9M+27.3% | $614.7M+25.8% | $604.0M+26.0% | $580.4M+18.1% | $538.2M+9.8% | $488.6M-2.4% | $479.3M-2.4% | $491.6M+1.6% |
| SG&A Expenses | $44.1M+0.6% | $43.7M+21.3% | $44.4M+9.5% | $45.3M+10.0% | $43.9M+29.4% | $36.0M-1.2% | $40.5M+10.0% | $41.2M+21.3% |
| Interest Expense | $22.3M+77.7% | $17.7M+16.1% | $17.8M+13.6% | $16.6M+3.9% | $12.5M-26.7% | $15.2M-18.2% | $15.7M-11.1% | $16.0M-10.6% |
| Income Tax | $10.4M-24.4% | $14.4M+106.3% | $9.7M+65.3% | $10.3M+12.8% | $13.7M+59.0% | $7.0Mn/m | $5.9M-42.7% | $9.1M+61.2% |
| Net Income | $37.1M-3.6% | $37.9M+51.0% | $26.5M+37.7% | $26.3M+24.7% | $38.5M+103.4% | $25.1M+163.2% | $19.3M-27.2% | $21.1M+51.9% |
| EPS (Basic) | $0.38+8.6% | $0.38+65.2% | $0.26+52.9% | $0.25+31.6% | $0.35+105.9% | $0.23+187.5% | $0.17-26.1% | $0.19 |
| EPS (Diluted) | $0.37+5.7% | $0.38+65.2% | $0.25+38.9% | $0.24+26.3% | $0.35+105.9% | $0.23+187.5% | $0.18-21.7% | $0.19 |
| Diluted Shares (Avg) | 99M-9.0% | 99M-9.8% | N/A | 107M-3.1% | 109M-2.1% | 109M-2.5% | N/A | 110M |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.
CXW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.5B+12.5% | $3.4B+12.2% | $3.3B+11.1% | $3.1B+6.7% | $3.1B+5.8% | $3.0B-0.8% | $2.9B-5.6% | $2.9B-5.0% |
| Current Assets | $666.9M+36.8% | $743.5M+79.8% | $611.1M+35.9% | $471.6M+13.3% | $487.4M+27.3% | $413.5M-3.0% | $449.8M-5.3% | $416.1M-0.9% |
| Cash & Equivalents | $108.9M-16.5% | $209.7M+181.5% | $97.9M-8.9% | $56.6M-47.6% | $130.5M+116.9% | $74.5M-33.1% | $107.5M-11.8% | $107.8M+4.0% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Accounts Receivable | $463.1M+54.1% | $479.8M+70.1% | $446.2M+54.5% | $351.4M+32.7% | $300.4M+9.8% | $282.1M+2.8% | $288.7M-7.5% | $264.8M-1.7% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $59.1M+1120.4% | $8.6M+76.5% | $8.6M+76.5% | $8.6M+76.5% | $4.8M0.0% | $4.8M0.0% | $4.8M0.0% | $4.8M0.0% |
| Total Liabilities | $2.0B+26.5% | $2.0B+29.2% | $1.9B+28.7% | $1.6B+14.0% | $1.6B+9.5% | $1.5B-3.6% | $1.4B-11.6% | $1.4B-10.7% |
| Current Liabilities | $505.7M+66.4% | $305.0M+14.4% | $368.9M+29.1% | $334.4M+21.7% | $304.0M+14.1% | $266.6M-26.9% | $285.8M-3.9% | $274.7M-9.7% |
| Non-Current Liabilities | $1.5B+17.2% | $1.7B+32.3% | $1.5B+28.6% | $1.3B+12.2% | $1.3B+8.5% | $1.3B+3.4% | $1.2B-13.4% | $1.2B-10.9% |
| Long-Term Debt | $1.2B+22.4% | $1.4B+42.4% | $1.2B+23.8% | $1.0B+5.0% | $1.0B-0.1% | $969.9M-1.4% | $973.1M-10.2% | $979.8M-7.2% |
| Total Equity | $1.4B-2.6% | $1.4B-5.4% | $1.4B-5.9% | $1.5B-0.4% | $1.5B+2.1% | $1.5B+2.2% | $1.5B+1.1% | $1.5B+1.2% |
| Retained Earnings | -$48.4Mn/m | -$85.6Mn/m | -$123.5Mn/m | -$150.0Mn/m | -$176.3Mn/m | -$214.9Mn/m | -$240.0Mn/m | -$259.3Mn/m |
Not reported in any period shown, so not listed: Inventory.
CXW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $133.0M+37.5% | $13.8M-69.0% | -$376K-101.0% | $53.8M-41.2% | $96.7M+42.1% | $44.5M-36.8% | $39.3M+75.9% | $91.5M+9.3% |
| Depreciation & Amortization | $35.8M+15.1% | $33.3M+9.2% | $33.9M+6.3% | $33.4M+3.6% | $31.1M-3.2% | $30.5M-3.8% | $31.9M-0.7% | $32.2M-0.9% |
| Stock-Based Compensation | N/A | $6.5M-0.3% | N/A | N/A | N/A | $6.5M+7.5% | N/A | N/A |
| Capital Expenditures | $38.1M+9.2% | $20.7M-15.7% | $44.8M+92.4% | $37.7M+111.4% | $34.9M+86.1% | $24.5M+131.0% | $23.3M-15.4% | $17.8M+1.4% |
| Free Cash Flow | $94.9M+53.5% | -$6.9M-134.7% | -$45.1M-381.8% | $16.1M-78.1% | $61.9M+25.4% | $20.0M-66.6% | $16.0Mn/m | $73.7M+11.3% |
| Investing Cash Flow | -$182.3Mn/m | -$22.8Mn/m | -$39.3Mn/m | -$106.7Mn/m | -$35.1Mn/m | -$25.0Mn/m | -$19.0Mn/m | -$13.4Mn/m |
| Financing Cash Flow | -$52.3Mn/m | $120.9Mn/m | $80.4Mn/m | -$18.3Mn/m | -$6.6Mn/m | -$53.7Mn/m | -$15.7M-287.3% | -$28.2Mn/m |
| Dividends Paid | N/A | N/A | $0n/m | $0n/m | $45K-61.2% | $0-100.0% | $0n/m | $0n/m |
| Share Buybacks | $48K-99.9% | $55.1M+8.9% | $95.1M+1087.0% | $40.0Mn/m | $43.3M+114.5% | $50.6M+3.3% | $8.0M-36.0% | $0n/m |
CXW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Net Margin | 5.4%-1.7pp | 6.2%+1.0pp | 4.4%+0.4pp | 4.5%+0.2pp | 7.2%+3.3pp | 5.1%+3.2pp | 4.0%-1.4pp | 4.3%+1.4pp |
| Return on Equity | 2.6%0.0pp | 2.7%+1.0pp | 1.9%+0.6pp | 1.8%+0.4pp | 2.6%+1.3pp | 1.7%+1.0pp | 1.3%-0.5pp | 1.4%+0.5pp |
| Return on Assets | 1.1%-0.2pp | 1.1%+0.3pp | 0.8%+0.1pp | 0.9%+0.1pp | 1.3%+0.6pp | 0.8%+0.5pp | 0.7%-0.2pp | 0.7%+0.3pp |
| Current Ratio | 1.32-0.3x | 2.44+0.9x | 1.66+0.1x | 1.41-0.1x | 1.60+0.2x | 1.55+0.4x | 1.570.0x | 1.51+0.1x |
| Debt-to-Equity | 0.86+0.2x | 0.99+0.3x | 0.86+0.2x | 0.700.0x | 0.680.0x | 0.660.0x | 0.65-0.1x | 0.66-0.1x |
| Liabilities-to-Equity | 1.40+0.3x | 1.41+0.4x | 1.32+0.4x | 1.12+0.1x | 1.08+0.1x | 1.04-0.1x | 0.96-0.1x | 0.97-0.1x |
| Asset Turnover | 0.200.0x | 0.180.0x | 0.190.0x | 0.190.0x | 0.180.0x | 0.160.0x | 0.160.0x | 0.170.0x |
| FCF Margin | 13.9%+2.4pp | -1.1%-5.2pp | -7.5%-10.8pp | 2.8%-12.2pp | 11.5%+1.4pp | 4.1%-7.8pp | 3.3%+4.4pp | 15.0%+1.3pp |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| CoreCivic, Inc. CXW | FY2025 | $2.2B | $116.5M | 5.3% | $3.0B | 56/100 |
| The GEO Group, Inc. GEO | FY2025 | $2.6B | $254.4M | 9.7% | $3.6B | 45/100 |
| Brady Corporation BRC | FY2026 | $1.7B | $205.4M | 12.4% | $3.8B | 77/100 |
| The Brink's Company BCO | FY2025 | $5.3B | $199.7M | 3.8% | $4.6B | 52/100 |
| Mine Safety Incorporated MSA | FY2025 | $1.9B | $278.9M | 14.9% | $7.0B | 64/100 |
| ADT Inc. ADT | FY2025 | $5.1B | $596.0M | 11.6% | $5.0B | 53/100 |
Where CoreCivic, Inc. Ranks
Frequently Asked Questions
What is CoreCivic, Inc.'s annual revenue?
CoreCivic, Inc. (CXW) reported $2.2B in total revenue for fiscal year 2025. This represents a 12.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is CoreCivic, Inc.'s revenue growing?
CoreCivic, Inc. (CXW) revenue grew by 12.7% year-over-year, from $2.0B to $2.2B in fiscal year 2025.
Is CoreCivic, Inc. profitable?
Yes, CoreCivic, Inc. (CXW) reported a net income of $127.9M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $116.5M, with a net profit margin of 5.3%.
How much debt does CoreCivic, Inc. have?
As of fiscal year 2025, CoreCivic, Inc. (CXW) had $97.9M in cash and equivalents against $1.2B in long-term debt.
What is CoreCivic, Inc.'s net profit margin?
CoreCivic, Inc. (CXW) had a net profit margin of 5.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is CoreCivic, Inc.'s return on equity (ROE)?
CoreCivic, Inc. (CXW) has a return on equity of 8.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is CoreCivic, Inc.'s free cash flow?
CoreCivic, Inc. (CXW) generated $52.8M in free cash flow during fiscal year 2025. This represents a -73.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is CoreCivic, Inc.'s operating cash flow?
CoreCivic, Inc. (CXW) generated $194.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are CoreCivic, Inc.'s total assets?
CoreCivic, Inc. (CXW) had $3.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are CoreCivic, Inc.'s capital expenditures?
CoreCivic, Inc. (CXW) invested $141.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is CoreCivic, Inc.'s current ratio?
CoreCivic, Inc. (CXW) had a current ratio of 1.66 as of fiscal year 2025, which is generally considered healthy.
What is CoreCivic, Inc.'s debt-to-equity ratio?
CoreCivic, Inc. (CXW) had a debt-to-equity ratio of 0.86 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is CoreCivic, Inc.'s liabilities-to-equity ratio?
CoreCivic, Inc. (CXW) had a liabilities-to-equity ratio of 1.32 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is CoreCivic, Inc.'s return on assets (ROA)?
CoreCivic, Inc. (CXW) had a return on assets of 3.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is CoreCivic, Inc.'s P/E ratio?
CoreCivic, Inc. (CXW) trades at 23.1x earnings, its market capitalization divided by $127.9M net income, trailing 12 months to June 30, 2026. The market capitalization is $3.0B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is CoreCivic, Inc.'s price-to-sales ratio?
CoreCivic, Inc. (CXW) trades at 1.2x sales, its market capitalization divided by $2.5B revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.0B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is CoreCivic, Inc.'s Piotroski F-Score?
CoreCivic, Inc. (CXW) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are CoreCivic, Inc.'s earnings high quality?
CoreCivic, Inc. (CXW) has an earnings quality ratio of 1.67x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is CoreCivic, Inc.?
CoreCivic, Inc. (CXW) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.